Skip to main content
Erschienen in: Pediatric Cardiology 6/2013

01.08.2013 | Original Article

Epidemiology and Risk Factors for Coronary Artery Abnormalities in Children With Complete and Incomplete Kawasaki Disease During a 10-Year Period

verfasst von: Georgia Giannouli, Chryssa Tzoumaka-Bakoula, Ioannis Kopsidas, Paraskevi Papadogeorgou, George P. Chrousos, Athanasios Michos

Erschienen in: Pediatric Cardiology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Kawasaki disease (KD) is an acute systemic vasculitis of childhood. The diagnosis is based on clinical criteria. However, the presentation of KD is incomplete/atypical for approximately 20 % of patients. Kawasaki disease is complicated with coronary artery lesions (CALs) and considered the most common cause of acquired heart disease in children. The medical records of children discharged with KD from a tertiary pediatric hospital in Athens, Greece, during a decade (2001–2010) were retrospectively analyzed. During the study period, KD was diagnosed for 86 children younger than 14 years of age. Complete diagnostic criteria were fulfilled by 64 of the children (74.4 %), whereas 25.6 % were considered incomplete cases. Cardiovascular complications were detected in 48 children (55.8 %) and CALs in 28 children (32.6 %). The prevalence of CALs did not differ significantly between complete and incomplete/atypical KD (42.2 vs 4.5 %; P = 0.001). Logistic regression analysis showed that erythema in the lips and oral cavity was associated with the development of CALs [odds ratio (OR), 3.03; 95 % confidence interval (CI), 1.051–8.783; P = 0.040]. Conversely, children with incomplete/atypical KD (OR, 0.092; 95 % CI, 0.010–0.816; P = 0.032) and previous antibiotic treatment (OR, 0.17; 95 % CI, 0.036–0.875; P = 0.034) were less likely to experience CALs. Children with an incomplete/atypical presentation of KD or before antibiotic treatment may be at lower risk for the development of CALs. Future multicenter studies may help to establish this association better.
Literatur
2.
3.
Zurück zum Zitat Belay ED et al (2006) Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis J 25:245–249PubMedCrossRef Belay ED et al (2006) Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis J 25:245–249PubMedCrossRef
5.
Zurück zum Zitat Checkley W et al (2009) Short-term weather variability in Chicago and hospitalizations for Kawasaki disease. Epidemiology 20:194–201PubMedCrossRef Checkley W et al (2009) Short-term weather variability in Chicago and hospitalizations for Kawasaki disease. Epidemiology 20:194–201PubMedCrossRef
6.
Zurück zum Zitat Dhillon R et al (1993) Management of Kawasaki disease in the British Isles. Arch Dis Child 69:631–636PubMedCrossRef Dhillon R et al (1993) Management of Kawasaki disease in the British Isles. Arch Dis Child 69:631–636PubMedCrossRef
7.
Zurück zum Zitat Durongpisitkul K et al (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057–1061PubMed Durongpisitkul K et al (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057–1061PubMed
8.
Zurück zum Zitat Durongpisitkul K et al (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145–148PubMedCrossRef Durongpisitkul K et al (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145–148PubMedCrossRef
9.
Zurück zum Zitat Egami K et al (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237–240PubMedCrossRef Egami K et al (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237–240PubMedCrossRef
10.
Zurück zum Zitat Ghelani SJ et al (2012) Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol 33:1097–1103PubMedCrossRef Ghelani SJ et al (2012) Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol 33:1097–1103PubMedCrossRef
11.
Zurück zum Zitat Holman RC et al (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997–2007. Pediatr Infect Dis J 29:483–488PubMed Holman RC et al (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997–2007. Pediatr Infect Dis J 29:483–488PubMed
12.
Zurück zum Zitat Honkanen VE et al (2003) Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 24:122–126PubMedCrossRef Honkanen VE et al (2003) Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 24:122–126PubMedCrossRef
13.
Zurück zum Zitat Kato H et al (1979) Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 63:175–179PubMed Kato H et al (1979) Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 63:175–179PubMed
14.
Zurück zum Zitat Kawasaki T et al (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271–276PubMed Kawasaki T et al (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271–276PubMed
15.
Zurück zum Zitat Kim T et al (2007) Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 166:421–425PubMedCrossRef Kim T et al (2007) Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 166:421–425PubMedCrossRef
16.
Zurück zum Zitat Kim SH et al (2009) Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr 46:585–590PubMed Kim SH et al (2009) Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr 46:585–590PubMed
17.
Zurück zum Zitat Kowalczyk M et al (2005) Kawasaki disease in children: 9 years experience. Med Wieku Rozwoj 9:179–193PubMed Kowalczyk M et al (2005) Kawasaki disease in children: 9 years experience. Med Wieku Rozwoj 9:179–193PubMed
18.
Zurück zum Zitat Leung DY et al (2002) Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr 140:742–746PubMedCrossRef Leung DY et al (2002) Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr 140:742–746PubMedCrossRef
19.
Zurück zum Zitat Manlhiot C et al (2012) Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 171:657–662PubMedCrossRef Manlhiot C et al (2012) Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 171:657–662PubMedCrossRef
20.
Zurück zum Zitat McCrindle BW et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179PubMedCrossRef McCrindle BW et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179PubMedCrossRef
21.
Zurück zum Zitat Muta H et al (2006) Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr 95:189–193PubMedCrossRef Muta H et al (2006) Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr 95:189–193PubMedCrossRef
22.
Zurück zum Zitat Nakamura Y et al (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46:33–38PubMedCrossRef Nakamura Y et al (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46:33–38PubMedCrossRef
23.
Zurück zum Zitat Nakamura Y et al (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 nationwide survey. J Epidemiol 22:216–221PubMed Nakamura Y et al (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 nationwide survey. J Epidemiol 22:216–221PubMed
25.
Zurück zum Zitat Newburger JW et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771PubMedCrossRef Newburger JW et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771PubMedCrossRef
26.
Zurück zum Zitat Rigante D et al (2011) Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int 30:841–846CrossRef Rigante D et al (2011) Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int 30:841–846CrossRef
27.
Zurück zum Zitat Sabharwal T et al (2009) Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. Am J Cardiol 104:1743–1747PubMedCrossRef Sabharwal T et al (2009) Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. Am J Cardiol 104:1743–1747PubMedCrossRef
28.
Zurück zum Zitat Sano T et al (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131–137PubMedCrossRef Sano T et al (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131–137PubMedCrossRef
29.
Zurück zum Zitat Schiller B et al (1995) Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr 84:769–774PubMedCrossRef Schiller B et al (1995) Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr 84:769–774PubMedCrossRef
31.
Zurück zum Zitat Stockheim JA et al (2000) Kawasaki disease in older children and adolescents. J Pediatr 137:250–252PubMedCrossRef Stockheim JA et al (2000) Kawasaki disease in older children and adolescents. J Pediatr 137:250–252PubMedCrossRef
32.
Zurück zum Zitat Sudo D et al (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171:651–656PubMedCrossRef Sudo D et al (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171:651–656PubMedCrossRef
33.
Zurück zum Zitat Tremoulet AH et al (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153:117–121PubMedCrossRef Tremoulet AH et al (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153:117–121PubMedCrossRef
34.
Zurück zum Zitat Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22:79–85PubMedCrossRef Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22:79–85PubMedCrossRef
35.
Zurück zum Zitat Wallace CA et al (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105:E78PubMedCrossRef Wallace CA et al (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105:E78PubMedCrossRef
Metadaten
Titel
Epidemiology and Risk Factors for Coronary Artery Abnormalities in Children With Complete and Incomplete Kawasaki Disease During a 10-Year Period
verfasst von
Georgia Giannouli
Chryssa Tzoumaka-Bakoula
Ioannis Kopsidas
Paraskevi Papadogeorgou
George P. Chrousos
Athanasios Michos
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 6/2013
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-013-0673-9

Weitere Artikel der Ausgabe 6/2013

Pediatric Cardiology 6/2013 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.